Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited - PubMed (original) (raw)
Review
. 2001 Oct;12(10):1353-7.
doi: 10.1023/a:1012504904713.
Affiliations
- PMID: 11762804
- DOI: 10.1023/a:1012504904713
Free article
Review
Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited
J T Tamsma et al. Ann Oncol. 2001 Oct.
Free article
Abstract
Peritonitis carcinomatosa, indicating the presence of malignant cells in the peritoneal cavity, is a well-known complication of malignant disease. As a result, so-called malignant ascites develops. Malignant ascites is a debilitating condition for which no effective anti-tumor therapy is available. Frequent draining may be necessary to relieve pain and discomfort. Most studies regarding malignant ascites focus on diagnosis and treatment. In this paper. we will address the subject from a pathophysiologic perspective, using the characteristics of malignant ascites, Starling's equation of capillary forces, and recent knowledge regarding biologically active peptides produced by tumor cells. Following this approach. apart from decreased lymphatic ascites absorption, increased net capillary fluid-production can be identified as a contributing feature of ascites formation. The increased net filtration is due to an increase of overall capillary membrane-surface, increased capillary permeability and a subsequent increase of intraperitoneal protein concentration leading to increased intraperitoneal oncotic pressure. This sequence might be the result of biologically active peptides produced by tumor cells such as vascular endothelial growth factor and basic fibroblast growth factor. Interference with these mediators may serve as a target in future therapeutic strategies.
Similar articles
- Ascites revisited: a novel role for tamoxifen.
Donovan D, Harmey JH, Redmond HP, Bouchier-Hayes D. Donovan D, et al. Eur J Surg Oncol. 1997 Dec;23(6):570. doi: 10.1016/s0748-7983(97)93461-2. Eur J Surg Oncol. 1997. PMID: 9484934 No abstract available. - Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. Nagy JA, et al. Cancer Res. 1995 Jan 15;55(2):360-8. Cancer Res. 1995. PMID: 7812969 - Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors.
Shaheen RM, Ahmad SA, Liu W, Reinmuth N, Jung YD, Tseng WW, Drazan KE, Bucana CD, Hicklin DJ, Ellis LM. Shaheen RM, et al. Br J Cancer. 2001 Aug 17;85(4):584-9. doi: 10.1054/bjoc.2001.1936. Br J Cancer. 2001. PMID: 11506500 Free PMC article. - The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B, Aboulghar M, Smitz J, Ron-El R. Rizk B, et al. Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review.
Cited by
- Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion.
Chen D, Song X, Shi F, Zhu H, Wang H, Zhang N, Zhang Y, Kong L, Yu J. Chen D, et al. Oncotarget. 2017 May 23;8(21):35262-35271. doi: 10.18632/oncotarget.13064. Oncotarget. 2017. PMID: 27823984 Free PMC article. - Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites.
Huang LL, Xia HH, Zhu SL. Huang LL, et al. J Clin Transl Hepatol. 2014 Mar;2(1):58-64. doi: 10.14218/JCTH.2013.00010. Epub 2014 Mar 15. J Clin Transl Hepatol. 2014. PMID: 26357618 Free PMC article. Review. - Respiratory distress due to malignant ascites palliated by hyperthermic intraperitoneal chemotherapy.
van den Houten MM, van Oudheusden TR, Luyer MD, Nienhuijs SW, de Hingh IH. van den Houten MM, et al. World J Gastrointest Surg. 2015 Mar 27;7(3):39-42. doi: 10.4240/wjgs.v7.i3.39. World J Gastrointest Surg. 2015. PMID: 25848491 Free PMC article. - Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.
Kulasingam V, Pavlou MP, Diamandis EP. Kulasingam V, et al. Nat Rev Cancer. 2010 May;10(5):371-8. doi: 10.1038/nrc2831. Epub 2010 Apr 12. Nat Rev Cancer. 2010. PMID: 20383179 Review. - Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis.
Cho JH, Kim SS. Cho JH, et al. J Belg Soc Radiol. 2020 Jan 30;104(1):8. doi: 10.5334/jbsr.1940. J Belg Soc Radiol. 2020. PMID: 32025624 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials